Daily non-political popular news in brief.

Forteo's bone-building power shown in arthritis patients

11-14-2007 · EurekAlert!

In a head-to-head comparison of the two drugs, Forteo increased lumbar spine density measurements by 7.2 percent compared to 3.4 percent for Fosamax, and it boosted hip density measurements by 3.8 percent compared to 2.4 percent for Fosamax. The study, by researchers at the University of Alabama at Birmingham, looked at changes in bone density over the course of 18 months in arthritis patients with prednisone-induced osteoporosis.

Keywords: forteo, bone-building, power, arthritis, patients, bone, building, arthriti, patient

« Previous | Next »

Similar news on "Forteo's bone-building power shown in arthritis patients":

MIT researchers probe bones' tiny building blocks
05-24-2007 · Massachusetts Institute of Technology (MIT)
In work that could lead to more effective diagnoses and treatments of bone diseases using only a pinhead-sized sample of a patient's bone, MIT researchers report a first-of-its-kind analysis of bone's mechanical properties.
Similar news · Read more »
JCI table of contents: December 1, 2006
12-01-2006 · EurekAlert!
This release contains summaries, links to PDFs, and contact information for newsworthy papers to be published December 1, 2006, in the JCI, including: Silencing the cause of mad cow disease; Immune responses spread from one protein to another in type 1 diabetes; Fat tissue gains weight from the bone marrow; Immune cells get together in the lung of patients with rheumatoid arthritis; PDE3B regulates energy levels in mice; and others.
Similar news · Read more »
Annals of Internal Medicine tip sheet for March 20, 2007
03-19-2007 · EurekAlert!
The following articles are featured in the upcoming Annals of Internal Medicine: "Flexible Use of Drugs with Close Patient Follow-up Can Successfully Control Rheumatoid Arthritis;" "Osteoporosis Drug Strengthens Bones in Men with Prostate Cancer," and "Experts Show Physicians How to Initiate and Carry Through Timely and Effective Discussions about Hospice with Dying Patients."
Similar news · Read more »
Geisinger rheumatologists redesign osteoporosis, rheumatoid arthritis care
11-16-2007 · EurekAlert!
Geisinger Health System recently improved the ordering process for DXA scans, more than quadrupling the number of patients who received a bone density test for osteoporosis. Testing for the painful disease is the first step in getting care to patients. Details of the new program were presented at the recent American College of Rheumatology conference, along with results of three other studies that cast new light osteoporosis and rheumatoid arthritis treatment.
Similar news · Read more »
Patient choice and treatment alternatives for arthritis
06-28-2007 · EurekAlert!
Two new studies examined patients' decisions regarding therapy for RA and glucosamine for OA and found that most RA patients are reluctant to change their treatment as long as their condition didn't worsen, and that there are discrepancies in clinical trial results for glucosamine.
Similar news · Read more »
Double trouble for RA patients: PLC-gamma-2 regulates osteoclastogenesis and B cell differentiation
10-19-2006 · EurekAlert!
Rheumatoid arthritis (RA) is caused by the immune system inappropriately attacking the joints. The autoimmune response also leads to the recruitment and/or differentiation of cells known as osteoclasts -- cells that degrade and resorb bone. Current treatments for RA target either the joint-specific immune response or the osteoclast-mediated bone erosion but a new study suggests that targeting a protein known as PLC-gamma-2 might lead to control of both immune-mediated joint destruction and osteoclast-mediated bone erosion.
Similar news · Read more »
Penn's Abramson Cancer Center part of major phase III study for myeloma
11-21-2007 · EurekAlert!
Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
Similar news · Read more »
Rheumatoid arthritis sends many into early retirement
02-04-2008 · EurekAlert!
A joint study on "The Burden of Rheumatoid Arthritis and Patient Access to Treatments" by authors from the Stockholm School of Economics, the University of Lund and the Medical University of Vienna has shown that the highest cost in rheumatoid arthritis results from patients having to leave the workforce early due to the disease. The study has just been published online in a supplement to Springer's The European Journal of Health Economics.
Similar news · Read more »
A faster way to recover from chemotherapy and marrow transplant
06-20-2007 · EurekAlert!
Researchers at Children's Hospital Boston report finding a practical way to increase stem cells in blood, suggesting a possible treatment to help patients recover from chemotherapy or bone marrow transplant for cancer, regaining immune function more quickly. The discovery, reported in the June 21 Nature and made possible through high-volume drug screening in fish, marks the first time stem-cell production has been induced by a small-molecule drug.
Similar news · Read more »
Adult stem cell heart attack study updated at American Society for Hematology Meeting
12-11-2007 · EurekAlert!
Doctors are using patients' own bone marrow stem cells (progenitor cells) to treat the damage to cardiac muscle after a heart attack in a study at Emory University School of Medicine. The study investigators will update their colleagues on its progress at the American Society of Hematology meeting in Atlanta next week.
Similar news · Read more »